miDiagnostics is now an Associate Member of Leuven MindGate

Leuven, Belgium   I   July 2019

.

Leuven is one of the world’s prime regions for health, high-tech and creativity. A region with a unique ecosystem of companies cooperating with knowledge institutions and the government, with MindGate creating a perfect breeding ground for companies, entrepreneurs, investors and talent.

Leuven MindGate brings parties together in a so-called Triple Helix model, consolidating the region’s position by improving the interdisciplinary relations between these sectors.

Leuven MindGate has two clear goals for the benefit of the whole region of Leuven:
  • Position the region internationally as a top destination in health, high-tech and creativity
    Leuven MindGate participates in national and international projects, missions, trade fairs and constantly aims to make Leuven MindGate worldwide top of mind when it comes to health, high-tech and creativity.
  • Strengthen the region’s eco(n)system for the benefit of local companies: Leuven MindGate improves cross-pollination between these sectors by letting them interact, cooperate, and co-create. This creates a unique ecosystem and perfect breeding ground for companies, entrepreneurs, investors and international talent.

For miDiagnostics, as an ambitious start-up based in Leuven, being a member of Leuven MindGate allows to be informed about and receive access to exclusive Leuven MindGate member activities and content and allows the opportunity to participate in local and international projects such as trade fairs and international missions.

Share this story

 

About miDIAGNOSTICS

miDiagnostics is using silicon chip technology which will bring miniaturized, rapid, easy-to-use, lab-quality tests with built-in connectivity direct to the patient and clinician.
Combining a nanofluidic processor on a chip and a compact reader, miDiagnostics can measure virtually any biomarker from an easily accessed sample such as drops of fingerprick blood. The Company is developing an extensive portfolio of tests for screening, diagnosis and monitoring of a wide range of health conditions, including infectious diseases.
Spun out of the world-leading R&D and innovation hub in nanoelectronics and digital technologies, imec, and a research collaboration with Johns Hopkins University, the leading US research and medical centre, miDiagnostics’ goal is to enable fast, comprehensive and cost-effective health analysis, regardless of location.  Based in Leuven, Belgium, miDiagnostics is a privately held company created in 2015.
Learn More

Share This

Copy Link to Clipboard

Copy